Patent · US Active

Pure erlotinib

US8952022B2 · kind B2 · utility

2Cited by

2References

30Claims

0Family size

Assignee

Generics [UK] Limited · GB

Inventors

Vinayak Govind Gore · Panvel, IN
Anilkumar Tripathi · Jamkhed, IN
Madhav Jadhav · Jamkhed, IN

Key dates

Filing date	Jul 22, 2011
Grant date	Feb 10, 2015
Priority date	—
Expiry date	Jul 22, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to processes for the preparation of erlotinib and salts and polymorphs thereof, preferably of high purity. The present invention also relates to erlotinib and salts and polymorphs thereof preparable by said processes, to medical uses of said erlotinib, salts and polymorphs, and to pharmaceutical compositions comprising the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.